Provided by Tiger Fintech (Singapore) Pte. Ltd.

Humacyte, Inc.

2.31
-0.2000-7.97%
Post-market: 2.350.0395+1.71%19:57 EDT
Volume:4.23M
Turnover:9.92M
Market Cap:358.32M
PE:-3.57
High:2.50
Open:2.50
Low:2.25
Close:2.51
Loading ...

Humacyte Shares Down 28.8% After Co Prices Public Offering of 25 Mln Shares at $2.00 per Share

THOMSON REUTERS
·
26 Mar

BRIEF-Humacyte To Present Fourth Quarter And Full Year Financial Results And Provide Corporate Update On March 28, 2025

Reuters
·
26 Mar

Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025

THOMSON REUTERS
·
26 Mar

Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025

GlobeNewswire
·
26 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Dollar Tree, GameStop, Humacyte

Reuters
·
26 Mar

BUZZ-Humacyte tumbles on pricing $50 mln stock offering

Reuters
·
26 Mar

US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking 'More Balanced' And Gone From 'Above-Trend To On-Trend,' Says Expert

Benzinga
·
26 Mar

Humacyte Prices $50 Million Stock Offering

MT Newswires Live
·
26 Mar

Humacyte Shares Down 23.5% Premarket After Co Prices Public Offering of 25 Mln Shares at $2.00 per Share

THOMSON REUTERS
·
26 Mar

BRIEF-Humacyte Prices Public Offering Of 25 Million Shares At $2.00 Per Share

Reuters
·
26 Mar

Humacyte Inc - Prices Public Offering of 25 Mln Shares at $2.00 per Share

THOMSON REUTERS
·
26 Mar

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

THOMSON REUTERS
·
26 Mar

Humacyte's Stock Drops Below 52-Week Low Amidst Share Sale

Dow Jones
·
26 Mar

BUZZ-Humacyte tumbles on planned equity raise

Reuters
·
26 Mar

Humacyte Inc - to Use Proceeds for Symvess Commercialization, Pipeline Development, Working Capital

THOMSON REUTERS
·
26 Mar

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
26 Mar

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

GlobeNewswire
·
26 Mar

Humacyte Inc expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
21 Mar

Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics

GlobeNewswire
·
10 Mar

Humacyte Partners With Trestle Biotherapeutics on Bioengineered Kidney Research

MT Newswires Live
·
06 Mar